share_log

NexImmune | DEFA14A: Others

NexImmune | DEFA14A: Others

NexImmune | DEFA14A：其他
美股sec公告 ·  07/11 15:13
Moomoo AI 已提取核心訊息
NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for July 11, 2024. The meeting has been rescheduled to July 19, 2024, and will be conducted virtually via live webcast. The purpose of the meeting is to seek stockholder approval for the proposed liquidation and dissolution of the company, as detailed in the Proxy Statement issued in June 2024. Stockholders of record as of June 11, 2024, are entitled to vote at the rescheduled meeting. NexImmune has provided various options for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or during the live webcast of the meeting. Votes can be submitted until 11:59 p.m. Eastern Time on July 18, 2024. The company has engaged Laurel Hill Advisory Group, LLC to assist stockholders with voting and inquiries. NexImmune's management has expressed appreciation for stockholders' prompt attention and continued confidence.
NexImmune, Inc. has announced the adjournment of its Special Meeting of Stockholders originally scheduled for July 11, 2024. The meeting has been rescheduled to July 19, 2024, and will be conducted virtually via live webcast. The purpose of the meeting is to seek stockholder approval for the proposed liquidation and dissolution of the company, as detailed in the Proxy Statement issued in June 2024. Stockholders of record as of June 11, 2024, are entitled to vote at the rescheduled meeting. NexImmune has provided various options for stockholders to submit their proxy votes, including over the Internet, by telephone, by mail, or during the live webcast of the meeting. Votes can be submitted until 11:59 p.m. Eastern Time on July 18, 2024. The company has engaged Laurel Hill Advisory Group, LLC to assist stockholders with voting and inquiries. NexImmune's management has expressed appreciation for stockholders' prompt attention and continued confidence.
NexImmune，Inc.宣佈將原定於2024年7月11日舉行的特別股東大會延期。該會議已改爲於2024年7月19日通過實時網絡廣播形式進行。會議的目的是徵求股東批准公司的擬議清算和解散，詳見2024年6月發佈的代理文件。截至2024年6月11日，股權登記簿上的股東有權在本次重新安排的會議上投票。NexImmune提供了多種選項供股東提交代理投票，包括通過互聯網、電話、郵寄或在會議現場實時網絡廣播期間進行。投票可以在2024年7月18日晚上11:59（美國東部時間）前提交。該公司已委託Laurel Hill Advisory Group，LLC協助股東進行投票和查詢。NexImmune的管理層對股東的及時關注和持續信任表示感激。
NexImmune，Inc.宣佈將原定於2024年7月11日舉行的特別股東大會延期。該會議已改爲於2024年7月19日通過實時網絡廣播形式進行。會議的目的是徵求股東批准公司的擬議清算和解散，詳見2024年6月發佈的代理文件。截至2024年6月11日，股權登記簿上的股東有權在本次重新安排的會議上投票。NexImmune提供了多種選項供股東提交代理投票，包括通過互聯網、電話、郵寄或在會議現場實時網絡廣播期間進行。投票可以在2024年7月18日晚上11:59（美國東部時間）前提交。該公司已委託Laurel Hill Advisory Group，LLC協助股東進行投票和查詢。NexImmune的管理層對股東的及時關注和持續信任表示感激。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息